436 related articles for article (PubMed ID: 32039788)
1. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
Samura O; Okamoto A
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
[TBL] [Abstract][Full Text] [Related]
2. Predicting fetoplacental mosaicism during cfDNA-based NIPT.
Neofytou M
Curr Opin Obstet Gynecol; 2020 Apr; 32(2):152-158. PubMed ID: 31977337
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
[TBL] [Abstract][Full Text] [Related]
4. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with "false negative" result due to confined placental mosaicism: A case report.
Li X; Ju D; Shi Y; Li Y; Dong H; Huang J; Zhang Y
Medicine (Baltimore); 2020 Jul; 99(29):e20848. PubMed ID: 32702826
[TBL] [Abstract][Full Text] [Related]
5. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
7. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy.
Mao J; Wang T; Wang BJ; Liu YH; Li H; Zhang J; Cram D; Chen Y
Clin Chim Acta; 2014 Jun; 433():190-3. PubMed ID: 24667696
[TBL] [Abstract][Full Text] [Related]
8. The significance of trisomy 7 mosaicism in noninvasive prenatal screening.
Qi Y; Yang J; Hou Y; Guo F; Peng H; Wang D; Du Q; Yin A
Hum Genomics; 2019 Apr; 13(1):18. PubMed ID: 30971315
[TBL] [Abstract][Full Text] [Related]
9. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
10. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?
Mennuti MT; Cherry AM; Morrissette JJ; Dugoff L
Am J Obstet Gynecol; 2013 Nov; 209(5):415-9. PubMed ID: 23529082
[TBL] [Abstract][Full Text] [Related]
11. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
12. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing.
Brison N; Neofytou M; Dehaspe L; Bayindir B; Van Den Bogaert K; Dardour L; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR
Prenat Diagn; 2018 Mar; 38(4):258-266. PubMed ID: 29388226
[TBL] [Abstract][Full Text] [Related]
13. Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results.
Raymond Y; Fernando S; Menezes M; Mol BW; McLennan A; da Silva Costa F; Hardy T; Rolnik DL
Am J Obstet Gynecol; 2024 Apr; 230(4):381-389. PubMed ID: 38008147
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.
Gil MM; Galeva S; Jani J; Konstantinidou L; Akolekar R; Plana MN; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Jun; 53(6):734-742. PubMed ID: 31165549
[TBL] [Abstract][Full Text] [Related]
16. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
[TBL] [Abstract][Full Text] [Related]
17. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
18. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
19. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
[TBL] [Abstract][Full Text] [Related]
20. Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran.
Garshasbi M; Wang Y; Hantoosh Zadeh S; Giti S; Piri S; Reza Hekmat M
Fetal Diagn Ther; 2020; 47(3):220-227. PubMed ID: 31487708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
